Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination
Authors
Keywords
Uterine cervical neoplasm, Adenocarcinoma, Papillomavirus infections, Human papillomavirus vaccines
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-11-21
DOI
10.1186/1471-2407-13-553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence and type distribution of human papillomavirus in cervical adenocarcinoma in Korean women
- (2013) Jong-Sup Park et al. GYNECOLOGIC ONCOLOGY
- Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
- (2012) Wiebren A. Tjalma et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16
- (2012) Jacolien van der Marel et al. INTERNATIONAL JOURNAL OF CANCER
- A novel blueprint for ‘top down’ differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia
- (2012) Michael Herfs et al. JOURNAL OF PATHOLOGY
- Unusual Endocervical Adenocarcinomas
- (2011) Kay J. Park et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with the Linear Array HPV Genotyping PCR Assay and Influence of DNA Extraction Method on HPV Detection
- (2011) C. C. Roberts et al. JOURNAL OF CLINICAL MICROBIOLOGY
- One virus, one lesion-individual components of CIN lesions contain a specific HPV type
- (2011) Wim Quint et al. JOURNAL OF PATHOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Absence of High-Risk Human Papillomavirus (HPV) Detection in Endocervical Adenocarcinoma with Gastric Morphology and Phenotype
- (2010) Yasuki Kusanagi et al. AMERICAN JOURNAL OF PATHOLOGY
- Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA
- (2010) Gerald Coquillard et al. GYNECOLOGIC ONCOLOGY
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of the performance of the novel PapilloCheck® HPV genotyping test by comparison with two other genotyping systems and the HC2 test
- (2010) Betti Schopp et al. JOURNAL OF MEDICAL VIROLOGY
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18
- (2009) Wen Chen et al. CANCER CAUSES & CONTROL
- Adenocarcinoma: A unique cervical cancer
- (2009) Lilian T. Gien et al. GYNECOLOGIC ONCOLOGY
- Screening and adenocarcinoma of the cervix
- (2009) Peter Sasieni et al. INTERNATIONAL JOURNAL OF CANCER
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
- (2009) Mark Schiffman et al. Infectious Agents and Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search